Orphenadrine Citrate
NDC 0185-0022, Orphenadrine Citrate, tablet, extended release, from Sandoz Inc.
- Product NDC
- 0185-0022
- Status
- Listed
- Labeler
- Sandoz Inc
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA040327
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0185-0022 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ORPHENADRINE CITRATE100 mg/1
Pharmacologic classes
Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0185-0022-01 | 00185002201 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0185-0022-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/239018ff-cec6-46de-ae9d-26c9ec034a32NADAC price for package 00185002201
GET /v1/drugs/nadac/00185002201
Use it
Look up 0185-0022 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0185-0022 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0185-0022. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.